Phase 3 Recruiting Academic/Other
This Phase III Trial will determine whether adjuvant chemotherapy (ACT) added to ovarian function suppression (OFS) plus endocrine therapy (ET) is superior to OFS plus ET in improving invasive breast cancer-free survival (IBCFS) among prem…
Sponsor: NRG Oncology
NCT ID: NCT05879926
Sites in New Mexico: - University of New Mexico Cancer Center — Albuquerque, New Mexico
- Presbyterian Kaseman Hospital — Albuquerque, New Mexico
- Memorial Medical Center-Las Cruces — Las Cruces, New Mexico
- Presbyterian Rust Medical Center/Jorgensen Cancer Center — Rio Rancho, New Mexico
Phase 3 Recruiting NIH
This phase III trial compares standard of care hormone therapy plus ribociclib to chemotherapy followed by hormone therapy plus ribociclib for the treatment of patients with high anatomic stage breast cancer with low risk of the cancer ret…
Sponsor: National Cancer Institute (NCI)
NCT ID: NCT07391774
Sites in New Mexico: - University of New Mexico Cancer Center — Albuquerque, New Mexico
Phase 3 Recruiting Industry
The goal of this study is to find out if the experimental product, sacituzumab govitecan-hziy (SG) in combination with pembrolizumab given after surgery, is effective and safe compared to the treatment of physician's choice (TPC) which inc…
Sponsor: Gilead Sciences
NCT ID: NCT05633654
Sites in New Mexico: - University of New Mexico — Albuquerque, New Mexico
- San Juan Oncology Associates — Farmington, New Mexico
Phase 3 Recruiting Industry
This is a Phase III open-label study to assess if camizestrant improves outcomes compared to standard endocrine therapy in patients with ER+/HER2 - early breast cancer with intermediate or high risk for disease recurrence who completed def…
Sponsor: AstraZeneca
NCT ID: NCT05774951
Sites in New Mexico: - Research Site — Farmington, New Mexico
- Research Site — Santa Fe, New Mexico
Phase 3 Recruiting Academic/Other
The purpose of this study is to generate evidence on an alternative dosing strategy for CDK4/6 inhibitors to help more patients with Metastatic Breast Cancer (MBC) (age ≥ 60 years) tolerate side effects and stay on treatment longer, to der…
Sponsor: American Society of Clinical Oncology
NCT ID: NCT06377852
Sites in New Mexico: - Lovelace Medical Center - Saint Joseph Square — Albuquerque, New Mexico
- Lovelace Women's Hospital — Albuquerque, New Mexico
- Presbyterian Kaseman Hospital — Albuquerque, New Mexico
- The University of New Mexico Comprehensive Cancer Center — Albuquerque, New Mexico
- Memorial Medical Center — Las Cruces, New Mexico
Phase 3 Recruiting Industry
This is a Phase III, randomised, open-label, 3-arm, multicentre, international study assessing the efficacy and safety of Dato-DXd with or without durvalumab compared with investigator's choice chemotherapy in combination with pembrolizuma…
Sponsor: AstraZeneca
NCT ID: NCT06103864
Sites in New Mexico: - Research Site — Albuquerque, New Mexico
Phase 3 Recruiting Industry
This phase 3 clinical trial compares the efficacy and safety of palazestrant with ribociclib to letrozole and ribociclib in women and men who have not received prior systemic anti-cancer treatment for advanced breast cancer.
Sponsor: Olema Pharmaceuticals, Inc.
NCT ID: NCT07085767
Sites in New Mexico: - Clinical Trial Site — Santa Fe, New Mexico
Phase 3 Recruiting Industry
The goal of this clinical trial is to assess the efficacy, safety and tolerability of the combination of lasofoxifene and abemaciclib compared to fulvestrant and abemaciclib for the treatment of pre- and postmenopausal women and men who ha…
Sponsor: LeonaBio
NCT ID: NCT05696626
Sites in New Mexico: - Presbyterian Kaseman Hospital — Albuquerque, New Mexico
- Presbyterian Rust Cancer Center — Rio Rancho, New Mexico
Phase 3 Recruiting Industry
Researchers are looking for other ways to treat breast cancer (BC) that is hormone receptor-positive and human epidermal growth factor receptor 2-negative (HR+/HER2-) and either unresectable locally advanced or metastatic. * HR positive (H…
Sponsor: Merck Sharp & Dohme LLC
NCT ID: NCT07060807
Sites in New Mexico: - Presbyterian Kaseman Hospital ( Site 0072) — Albuquerque, New Mexico
- University of New Mexico Comprehensive Cancer Center ( Site 0047) — Albuquerque, New Mexico
- Presbyterian Rust Jorgensen Cancer ( Site 0073) — Rio Rancho, New Mexico
Phase 3 Recruiting Industry
This is a Phase 3, open-label, randomized, clinical trial evaluating the efficacy and safety of gedatolisib and palbociclib plus endocrine therapy for the treatment of patients with locally advanced or metastatic HR+/HER2- advanced breast …
Sponsor: Celcuity Inc
NCT ID: NCT06757634
Sites in New Mexico: - Christus Saint Vincent Regional Cancer Center — Santa Fe, New Mexico
Phase 2 Recruiting NIH
This ComboMATCH patient screening trial is the gateway to a coordinated set of clinical trials to study cancer treatment directed by genetic testing. Patients with solid tumors that have spread to nearby tissue or lymph nodes (locally adva…
Sponsor: National Cancer Institute (NCI)
NCT ID: NCT05564377
Sites in New Mexico: - University of New Mexico Cancer Center — Albuquerque, New Mexico
Recruiting Industry
International registry for cancer patients evaluating the feasibility and clinical utility of an Artificial Intelligence-based precision oncology clinical trial matching tool, powered by a virtual tumor boards (VTB) program, and its clinic…
Sponsor: Massive Bio, Inc.
NCT ID: NCT03452774
Sites in New Mexico: - Massive Bio SYNERGY-AI site — Albuquerque, New Mexico
NA Recruiting Industry
The purpose of this study is to evaluate the efficacy and safety of ctDNA-guided initiation of CDK4/6 inhibitor therapy using the Signatera™ Designed on Genome test (referred to as "Signatera Genome") in participants with intermediate-risk…
Sponsor: Natera, Inc.
NCT ID: NCT07214532
Sites in New Mexico: - New Mexico Oncology & Hematology Consultants — Albuquerque, New Mexico
NA Recruiting Academic/Other
Investigators aim to conduct a type 1 hybrid effectiveness-implementation surgeon-level cluster randomized clinical trial (RCT) of a multi-level intervention, a shared decision making training for surgeons plus patient decision aid vs. usu…
Sponsor: Beth Israel Deaconess Medical Center
NCT ID: NCT06896474
Sites in New Mexico: - University of New Mexico — Albuquerque, New Mexico